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Microfracture is the established proce-
dure for treatment of symptomatic Inter-
national Cartilage Repair Society (ICRS) 
grade III–IV cartilage defects of the ta-
lus [25]. The purpose of subchondral 
bone perforation, as in microfracture, is 
to enhance chondral resurfacing by pro-
viding a suitable environment for new tis-
sue formation. The released progenitor 
cells, mesenchymal stem cells, growth fac-
tors and other cytokines form a surgical-
ly induced superclot, which provides an 
enriched environment for fibrous carti-
lage formation. In defects with subchon-
dral cyst formation, microfracture can be 
combined with cyst resection and filling 
of the defect with bone graft from the ili-
ac crest, the tibia or the calcaneus. Com-
pared to all other cartilage repair tech-
niques, the level of evidence for good clin-
ical outcome is highest for microfracture 
[17]. However, the good initial clinical re-
sults are reported to begin to lessen after 
5 years [11, 19]. Significantly poorer results 
have been reported for defects exceeding 
1.5 cm2 [4, 5].
Autologous chondrocyte implantation 
(ACI) has increasing gained popularity 
for the treatment of larger defects during 
the past few years. ACI is a procedure in 
which cartilage cells harvested from the 
patient are expanded in vitro and then 
implanted into the joint in a second in-
tervention. The superiority of this expen-
sive and time-consuming cartilage recon-
struction technique over that of micro-
fracture could not be conclusively estab-
lished so far [9, 10, 20]. Current research is 
focused on one-step procedures, e.g. scaf-
fold-enhanced microfracture, with the 
goal of providing a simple, cost-effective 
clinical solution that avoids the problems 
associated with cell culture and a second 
surgical intervention [8, 28].
In larger defects, stabilization of the 
progenitor cell-containing blood clot 
formed after microfracture presents a 
problem [18]. By stabilizing this superclot 
with a biomaterial, the colonization, pro-
liferation and chondrogenesis of mesen-
chymal stem cells are facilitated [3, 12].
Autologous matrix-induced chondro-
genesis (AMIC) is a cartilage repair tech-
nique in which, after microfracturing, a 
collagen type I/III bilayer matrix (Chon-
dro-Gide®, Geistlich Pharma AG, Swit-
zerland) is secured over the cartilage de-
fect using commercially available fibrin 
glue. Mesenchymal progenitor cells mi-
grate toward and adhere to the porous 
 layer of the matrix; the cell-occlusive com-
pact layer prevents cell loss through leak-
age into the joint space and protects cells 
from mechanical stress. In vitro studies 
have shown that the stability of the colla-
gen matrix form prevents shrinkage of the 
super clot. Furthermore, its use in combi-
nation with fibrin glue (Tissucol or Tis-
seel from Baxter Healthcare, Deerfield, IL, 
USA) supports chondrogenic differenti-
ation of human mesenchymal stem cells 
and significantly enhances proteoglycan 
deposition [6, 22].
The controversial in vitro evidence on 
the effects of fibrin glue on mesenchy-
mal stem cells and chondrocytes has been 
a topic of discussion for well over a de-
cade. In rabbit experiments, Brittberg et al. 
[2] found that the use of Tisseel impaired 
healing of osteocondral defects and also 
reported that no cell migration into Tis-
seel took place, whereas cell migration 
was observed into blood clots. In con-
trast, Homminga et al. [13] have shown 
that chondrocytes in fibrin glue produce 
extracellular matrix, retain their typical 
morphology and divide to form colonies. 
Nowadays, commercially available fibrin 
glue is routinely used in orthopedics. It is 
also standard in matrix-induced autolo-
gous chondrocyte implantation (MACI) 
and no negative results have been report-
ed. Its use is supported by the findings of 
Sage et al. [23], who stated that fibrin glue 
increases proliferation of and glycosami-
noglycan production by cells in cartilage 
chips. Kirilak et al. [15] found that fibrin 
sealant promotes migration and prolifera-
tion of human articular chondrocytes and 
that thrombin, an active component of fi-
brin glue, stimulates these processes.
Alternative techniques for treatment 
of focal cartilage defects in the talus are 
the osteochondral autograft transfer sys-
tem (OATS), allograft or implantation of 
in vitro cultured autologous chondrocytes 
in ACI [1, 14, 24]. The OATS approach is 
associated with high donor site morbidi-
ty. In more than 50% of cases, complaints 
in the knee joint from where the grafts 
were harvested were reported [26]. Fur-
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thermore, an autograft cannot be implant-
ed in the ankle without an osteotomy of 
the medial or lateral malleolus, which can 
lead to future complications and late ad-
verse effects. Allograft is hardly available 
in Europe.
Surgical principle and objective
The objective of the procedure is 
treatment of a talar dome osteochon-
dral lesion (OCL) by microfracture in 
combination with a collagen matrix. 
The purpose of the collagen matrix is 
to retain and stabilize the superclot 
in the defect zone, as well as to pro-
tect it from being displaced [3, 12]. In 
most cases, the collagen matrix can 
be implanted without having to per-
form an osteotomy of the medial or 
lateral malleolus [29].
Advantages
F		Technically simple surgical procedure
F		Availability of the collagen matrix as a 
ready-to-use product with long shelf-
life (Chondro-Gide®)
F		One-step intervention
F		No donor site morbidity
F		In almost all cases the matrix can be 
implanted via miniarthrotomy alone, 
without the need for osteotomy of the 
lateral or medial malleolus
F		Saves of 90% of costs compared to 
cartilage reconstruction with in vitro 
cultured chondrocytes
Disadvantages
F		Additional costs of the matrix and 
fibrin glue as compared to microfrac-
ture alone
Indications
F		OCL of the talus (ICRS grades III 
and IV) >1.5 cm2
F		Osteochondrosis dissecans
F		Instability and axis malalignment 
do not represent contraindications 
if these can be addressed along with 
cartilage reconstruction
Contraindications
F		Generalized degenerative changes in 
the joint
F		Cartilage defects in the correspond-




F		Inferior results in older patients are 
more likely, although there is no clear 
age limit for the procedure
Patient information
F		Lower leg in plaster cast for 2 weeks
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Reconstruction of focal cartilage defects in the talus 
with miniarthrotomy and collagen matrix
Abstract
Surgical principal and objective. Treatment 
of focal cartilage defects (traumatic or osteo-
chondrosis dissecans) of the talus using a col-
lagen matrix. The goal is to stabilize the su-
perclot formed after microfracturing to ac-
commodate cartilage repair. The procedure 
can be carried out via miniarthrotomy, with-
out medial malleolus osteotomy.
Indications. International Cartilage Repair 
Society (ICRS) grade III and IV focal cartilage 
defects of the talus >1.5 cm2.
Contraindications. Generalized osteoarthri-
tis, inflammatory joint disease, gout, neuro-
arthropathy.
Surgical technique. Miniarthrotomy to 
open the ankle joint. Debridement of unsta-
ble cartilage and necrotic bone, curettage 
of cysts. Filling of the bone defects with au-
tologous cancellous bone. Sealing of recon-
structed bone with fibrin glue and attach-
ment of a collagen matrix shaped to precise-
ly fit the defect.
Postoperative regimen. Immobilization 
for 48 h. Partial weight bearing of 10 kg for 
6 weeks, with continuous passive motion. In-
creasing weight bearing from 7 weeks on-
wards.
Results. Follow-up of at least 30 months 
in 14 patients showed improvement in the 
Score of the American Orthopedic Foot and 
Ankle Society (AOFAS) from 50 to 89 points, 
with equal mobility on both sides of the up-
per ankle joint.
Keywords
Osteochondrosis dissecans · Microfracture · 
Ankle joint · Autograft · Chondrogenesis 
Rekonstruktion umschriebener Knorpeldefekte des 
Talus mittels Miniarthrotomie und Kollagenmatrix
Zusammenfassung
Operationsziel. Therapie von um-
schriebenen Knorpeldefekten (traumatisch 
oder durch Osteochondrosis dissecans) des 
Talus mit einer Kollagenmatrix. Ziel ist es, 
den Superclot nach der Mikrofrakturierung 
zu stabilisieren und die Regeneration von 
Faserknorpel zu unterstützten. Der Eingriff 
kann über eine Miniarthrotomie ohne Innen-
knöchelosteotomie durchgeführt werden.
Indikationen. Umschriebene Knorpeldefek-
te des Talus (Grad III und IV nach Internation-
al Cartilage Repair Society, ICRS) >1,5 cm2.
Kontraindikationen. Generalisierte degen-
erative Gelenkveränderungen, entzündliche 
Gelenkerkrankung, Gicht, Neuroarthopathie.
Operationstechnik. Eröffnung des Sprung-
gelenks über eine Miniarthrotomie. Débride-
ment von instabilem Knorpel, nekrotisch-
em Knochen und Zysten. Füllung von Kno-
chendefekten mit autologer Spongiosa. 
Versiegeln der Spongiosaplastik mit Fibrin-
kleber und Einkleben einer passgenau zuge-
schnittenen Kollagenmatrix.
Weiterbehandlung. 48 h Ruhigstellung, 
6 Wochen Teilbelastung 10 kg und Motor-
schiene. Ab der 7. Woche stufenweiser Belas-
tungsaufbau.
Ergebnisse. Bei 14 Patienten mit einem Fol-
low-up von mindestens 30 Monaten konnte 
eine Verbesserung des AOFAS-Scores (Amer-
ican Orthopedic Foot and Ankle Society) von 
50 auf 89 Punkte beobachtet werden, bei 
seitengleicher Beweglichkeit des oberen 
Sprunggelenks.
Schlüsselwörter
Osteochondrosis dissecans · Mikrofrak-
tur · Sprunggelenk · Autologes Transplantat · 
Chondrogenese
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F		Weeks 1–6: partial weight bearing 
of 10 kg, continuous passive motion 
(CPM), physiotherapy
F		Weeks 7–12: step-wise increase in 
weight bearing (about 20 kg every 
2 weeks)
F		Harvesting cancellous bone (calcane-
us, head of tibia, pelvic crest)
F		Possible disturbed mobility of ankle 
with need for surgical revision
F		Possible delayed or absent healing of 
the cancellous bone graft
F		Possible delayed or absent fibrocarti-
lage formation
F		Possible intolerance to the materials 
used
F		Possible tendency of swelling for 
several months
F		Possible wound healing disturbances, 
sensibility disturbances and/or circu-
lation disorders that can lead to loss 
of the foot
F		Inability to work: in most cases, work-
ing in a sitting position is allowed af-
ter 2 weeks and working in a stand-
ing position after 12 to 14 weeks. 
Occupations with greater physical 
demands can be undertaken within 
6 months
F		General risks of surgery
Preoperative workup
F		Clinical assessment of joint stability 
and hindfoot alignment
F		X-ray of the ankle in two planes. In 
instances of clinical suspicion of ax-
ial malalignment, additional radio-
graphs of the lower leg with the pa-
tient standing on one foot and a ra-
diograph of the hindfoot according to 
Saltzman are recommended
F		MRI of the ankle for assessment of 
cartilage lesions, possible subchon-
dral cysts, areas of necrotic bone and 
other accompanying pathologies
F		Documentation of circulation in the 
foot (posterior tibial and dorsalis pe-
dis artery pulse; if needed, Doppler 
sonography, capillary refill time)
F		Documentation of sensibility (distin-
guish between sharp/dull, two-point 
discrimination)
F		General preparations for surgery. Ac-
cording to guidelines published 
by the Robert Koch Institute (RKI 
Guidelines, http://www.rki.de), shav-
ing can be omitted
Instruments and implants
F		Basic set of surgical instruments for 
ankle surgery
F		Self-retaining Kirschner wire (K-
wire) distractor (.	Fig. 1)
F		Collagen matrix (Chondro-Gide® in 
different sizes)
F		Fibrin glue (e.g. Tissucol, Baxter 
Gmbh, Unterschleißheim, Germany)
F		Image intensifier if osteotomy or axial 
correction is planned
Anesthesia and positioning
F		Intubation, larynx mask, spinal or 
conduction anesthesia
F		Tourniquet (100 mmHg above the 
systolic blood pressure) at the upper 
thigh
F		Radiation protection mat from the 
head down to the middle of the lower 
thigh
F		Supine position
Fig. 1 9 Self-retaining 
Kirschner wire (K-wire) 
distractor (courtesy of 




(.	Fig. 2, 3, 4, 5, 6, 7, 8, 9)
Fig. 4 8 After dissection to the level of the joint 
capsule, the joint is opened by a longitudinal in-
cision. A 2.0-mm K-wire is drilled into the dis-
tal tibia, a second one parallel to the first in the 
neck of the talus. The talar K-wire is placed at 
the cartilage-free area ventral to the medial ta-
lar shoulder, in order to avoid cartilage damage. 
Placing the wires using the K-wire distractor as 
a drill guide facilitates precise positioning of the 
wires. The joint is then distracted in maximum 
plantar flexion
Fig. 5 8 Unstable cartilage is radically  debrided. 
In the border region, a stable cartilage edge 
must mark the transition to healthy cartilage. 
Oval-shaped preparation of the defect facili-
tates insertion of the collagen matrix. All necrot-
ic bone is removed and cysts curetted. The un-
derlying sclerotic zone is then perforated using 
multiple small drill holes (1.2-mm K-wire) with 
adequate cooling or microfracture awls. Particu-
larly in cases with a thick sclerotic wall visible 
in the preoperative MRI, drilling is preferred to 
completely perforate the sclerosis. In full-thick-
ness cartilage defects without additional sclero-
sis, microfracturing is sufficient, avoiding ther-
mal damage to the bone
Fig. 6 8 Osseous defects of 2 mm or more are 
reconstructed to the level of the subchondral 
bone lamella using autologous cancellous bone. 
Particular attention must be paid to ensure that 
the bone graft does not exceed the level of the 
subchondral bone lamella, which can lead to 
delamination of the collagen matrix. Cancellous 
bone harvested from the ipsilateral calcaneus is 
adequate in most cases. It is also possible to har-
vest cancellous bone from the tibial head or pel-
vic crest. Although the content of stem cells in 
iliac crest bone is higher than in the calcaneus, 
there is currently no clinical evidence that this 
has any impact on clinical outcome [7, 21]. The 
bone graft is sealed with fibrin glue, which pro-
vides sufficient stability to reconstruct even the 
talar shoulder
Fig. 2 9 Most osteo-
chondral lesions (OCLs) 
of the talus are locat-
ed at the medial talar 
shoulder. The ventro-
medial approach is car-
ried out between the 
medial malleolus and 
the anterior tibial ten-
don (tibialis anterior 
tendon). N nerve
Fig. 3 8 The skin incision is marked medial 
between the medial malleolus and the anterior 




F		Depending on the location of the car-
tilage defect, other approaches can 
be used to facilitate access to the dis-
eased cartilage area. With a central 
approach, the entire ankle joint can 
be well visualized. This approach is 
particularly useful for treating defects 
of the medial and lateral talar shoul-
der, as well as for centrally located de-
fects. The ventrocentral access ap-
proach uses the space between the an-
terior tibial and the extensor hallucis 
longus tendons (.	Fig. 10). The neu-
rovascular bundle is retracted lateral-
ly using a blunt Hohmann retractor.
F		The ventrolateral approach (Ollier ap-
proach) is carried out lateral to the 
peroneus tertius tendon, ventral to 
the lateral malleolus (.	Fig. 11). Le-
sions of the lateral talar shoulder can 
be addressed well with this approach. 
The closure of the capsule can be 
combined with an external ligaments 
stabilization procedure.
F		Dorsal approaches are seldom neces-
sary, since with adequate distraction 
of the joint using the K-wire distrac-
tor (.	Fig. 1), more dorsally located 
defects can also be accessed. If such 
an approach is planned, the patient is 
positioned on the contralateral side in 
the case of a dorsolateral defect. The 
affected leg is positioned free, in or-
der to be able to flex the knee to al-
low for adequate dorsal extension of 
the ankle joint. The dorsolateral ap-
proach runs dorsal to the lateral mal-
leolus and enables medial or later-
al retraction of the peroneal tendons 
(.	Fig. 12).
F		For a dorsomedial approach between 
the medial malleolus and the poste-
rior tibial tendon (.	Fig. 13), the pa-
tient is positioned on the affected side. 
The contralateral leg is well-padded 
and the affected leg is positioned in 
a freely moveable manner. The use 
of a short vacuum mattress consid-
erably facilitates the procedure. Ade-
quate flexion of the knee is necessary 
to allow free dorsiflexion of the ankle 
joint.
F		Any axial deformities or instabilities 
present should be addressed with-
in the context of this intervention. 
Hindfoot deformity corrections, as 
well as capsule and ligament recon-
structions can be carried out accord-
ing to standard surgical techniques. 
.	Fig. 14 shows a patient with hind-
foot varus undergoing a concurrently 
performed closing wedge osteotomy 
of the calcaneus.
Postoperative management
F		Complete immobilization of the an-
kle at 90° for 48 h. If inserted, remove 
drain after 48 h. Begin with continu-
ous passive motion limited to 20–0–
20°, to provide continuous contain-
ment of the defect by the tibia dur-
Fig. 7 8 The defect size is measured with the 
help of an aluminum foil, which is pressed in-
to the defect with forceps such that the bor-
ders of the cartilage are clearly depicted. It is 
then cut to size and its exact fit is checked once 
again. The collagen matrix, hydrated in a physio-
logical saline solution, is cut to shape with the 
help of the template. When hydrated, the ma-
trix expands by 10–15%. The collagen matrix 
has a rough side that should face the bone; the 
smooth side faces the joint
Fig. 8 8 The cancellous bone graft is covered 
with commercially available fibrin glue and the 
collagen matrix is glued on top. Additional su-
turing is not required. To decrease the risk of de-
lamination when the joint is moved, care should 
be taken not to overlap the matrix with the edg-
es of the adjacent cartilage. After hardening of 
the glue, the distractor is removed and the joint 
moved throughout the range of motion  several 
times. If delamination occurs, possible matrix 
protrusion with the adjacent cartilage should be 
assessed and eliminated by shaving off excess 
matrix. Bone graft exceeding the level of the 
subchondral bone can also lead to delamination 
of the matrix. In this case, excess graft should be 
reduced before reattaching the matrix
Fig. 9 8 Finally, the joint is closed in layers with 
resorbable suture material. A drain without suc-
tion can be inserted if necessary. After applying 
an elastic compression bandage, the tourniquet 
is released. The ankle is immobilized with a dor-
sal plaster splint for the first 48 h after surgery
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ing the healing period and to mini-
mize the risk of delamination. In de-
fects located very ventral or dorsal to 
the joint surface, the recommended 
range of motion is modified accord-
ingly.
F		Dorsal splint for 2 weeks until wound 
healing is complete.
F		Weeks 1–6: partial weight bearing of 
10 kg.
F		Weeks 7–12: stepwise increase in 
weight bearing (increasing by 20 kg 
every 2 weeks).
F		From week 13 onward, daily activities 
including cycling and swimming are 
permitted.
F		Sports involving impact load or a 
rapid change of direction should be 
avoided for at least 12 months.
F		Whether or not a return to profes-
sional sports is possible after cartilage 
reconstruction has not yet been con-
clusively established.
F		There is no indication for routine 
MRI follow-up. However, if the pa-
tient complains of persistent pain, 
MRI is indicated.
Fig. 13 8 Dorsomedial approach between the medial malleolus (malleolus medialis) and the posterior 
tibial tendon, as indicated by the dashed red line. M muscle, A artery, N nerve
Fig. 14 8 Concurrently performed closing 
wedge osteotomy of the calcaneus in a patient 
with hindfoot varus
Fig. 10 8 Ventrocentral approach between the 
anterior tibial and the extensor hallucis longus 
tendon, as indicated by the dashed red line
Fig. 11 9 Ventrolater-
al approach (Ollier ap-
proach) lateral to the 
peroneus terzius ten-
don and ventral to the 
lateral malleolus (mal-
leolus lateralis), as in-
dicated by the dashed 
red line. A artery, N 
nerve
Fig. 12 8 Dorsolateral approach dorsal to the 
lateral malleolus, as indicated by the dashed red 
line. M muscle, A artery
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Errors, hazards and 
complications
F		If the OCL cannot be reached ade-
quately, an additional osteotomy 
should be considered. Ventral access 
can be extended by a v-shaped osteo-
tomy of the tibial plafond located di-
rectly over the lesion. The dorsomedi-
al approach can be enlarged by a me-
dial malleolar osteotomy; the dorso-
lateral approach by an osteotomy of 
the fibula.
F		Intraoperative delamination of the 
matrix can be addressed by elimina-
tion of matrix protrusion at the edge 
of the adjacent cartilage. If the bone 
graft is too thick, the surface layer 
should be ablated and the matrix reat-
tached.
F		Deep wound infection should be 
managed by a wound swab, early sur-
gical debridement and appropriate 
antibiotic treatment. In the case of 
joint involvement, repeated joint la-
vage may be necessary until clinical 
and systemic infection signs regress.
F		Incomplete healing of bone graft with 
recurring cyst formation [27]. Repe-
tition of the intervention is possible. 
However, after failure of initial sur-
gery, it is important to reassess axial 
malalignment or instability as possi-
ble causes.
Results
Postoperative results for a follow-up pe-
riod of 30 months or more are available 
for 14 patients with medial talar cartilage 
defects (ICRS grades III and IV>1.5 cm2). 
Patients were treated with AMIC as de-
scribed (.	Tab. 1). No intraoperative 
complications were observed. In 10 cas-
es, a cancellous bone graft from the cal-
caneus was used. The Score of the Ameri-
can Orthopedic Foot and Ankle Society 
(AOFAS, based on the score established 
by Kitaoka [16]) improved from 50.1±9.7 
to 89.0±9.3. In 2 patients, MRI revealed 
new cyst formation. In 1 patient, residu-
al complaints necessitated repeat arthros-
copy, which showed an unstable graft and 
hypertrophic repair tissue with impinge-
ment. In all other cases, MRI revealed 
good defect filling without increased ef-
fusion (.	Fig. 15).
Further sufficiently powered, random-
ized clinical trials with uniform method-
ology and validated outcome measures 
are needed to compare the results of sur-
gical strategies for treating OCLs of the ta-
lus. The results suggest that AMIC may be 
an effective way to treat full-thickness le-
sions of the talus without harvesting chon-
drocytes from the talus in patients who do 
not respond to initial curettage.
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Fig. 15 8 Complete coverage of the former de-
fect at 1-year follow-up evaluation (courtesy of 
My medibook GmbH)
Tab. 1 Results of 14 patients with cartilage defects of the medial talus treated by a medial 













1 F 24 2.0 Yes 62 37 97
2 F 22 1.5 Yes 47 37 90
3 M 49 1.5 Yes 49 36 85
4 M 40 2.0 Yes 50 36 97
5 F 31 1.5 No 53 35 100
6 M 45 1.5 Yes 71 35 66
7 F 41 1.5 No 53 35 78
8 M 22 2.0 Yes 63 33 87
9 F 29 2.0 Yes 35 33 90
10 M 26 3 No 43 32 87
11 F 49 2.5 No 39 32 97
12 F 57 1.5 Yes 47 31 85
13 F 16 2.0 Yes 47 30 100
14 M 28 3.0 Yes 43 30 87
    Mean 50.14 33.71 89.00
    SD ±9.78 ±2.46 ±9.32
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Fortschritte in der Diagnostik und die Ent-
wicklung neuer verbesserter Operations-
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Einen Einblick in die neuesten Entwicklun-
gen auf dem Gebiet der Kinderorthopädie 
bietet Der Orthopäde in Ausgabe 12/2013 
mit dem Schwerpunkt „Aktuelle pädia-
trische Orthopädie“.
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F Aktuelle Behandlungsstrategie des Mor-
bus Perthes
F Indikationsspektrum intramedullärer 
oder fixateurgebundener Achskorrek-
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F Knochenersatzmaterialien in der 
Therapie zystischer Tumoren des  
wachsenden Skeletts
Bestellen Sie diese Ausgabe zum Preis von 
37,- EUR zzgl. Versandkosten bei







Suchen Sie noch mehr zum Thema? Mit 
e.Med, dem Online-Paket von Springer 
Medizin, können Sie schnell und kom-
fortabel in über 500 medizinischen 
Fachzeitschriften recherchieren. Weitere 
Infos unter springermedizin.de/eMed.
